Standard treatment for Helicobacter pylori infection is suboptimal in non-ulcer dyspepsia compared with duodenal ulcer in Chinese-Reference-Cited by-同舟云学术

Standard treatment for Helicobacter pylori infection is suboptimal in non-ulcer dyspepsia compared with duodenal ulcer in Chinese

Published:2005-01 Issue:1 Volume:21 Page:73-81
ISSN:0269-2813
Container-title:Alimentary Pharmacology and Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Wong W. M.,Xiao S. D.,Hu P. J.,Wang W. H.,Gu Q.,Huang J. Q.,Xia H. H.-X.,Wu S. M.,Li C. J.,Chen M. H.,Cui Y.,Lai K. C.,Hu W. H. C.,Chan C. K.,Lam S. K.,Wong B. C.-Y.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2004.02283.x/fullpdf

Reference30 articles.

1. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection

2. Current concepts in the management of Helicobacter pylori infection-The Maastricht 2-2000 Consensus Report

3. Omeprazole plus Amoxicillin for Cure of Helicobacter pylori Infection Factors Influencing the Treatment Success

4. Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment

5. Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Implications of Helicobacter pylori Antibiotic Resistance in Italy: A Review of the Literature;Antibiotics;2022-10-21

2. Clinical Factors Implicated in Antibiotic Resistance in Helicobacter pylori Patients;Microorganisms;2022-01-29

3. Evaluation of anti-inflammatory, cytotoxic, anti-H. pylori, antioxidant activities, and phytochemical compositions of Shirakiopsis indica (Willd.) Esser;ScienceAsia;2021

4. The prolongation effect of ilaprazole-based standard triple therapy for Helicobacter pylori;Medicine;2020-09-18

5. Impact of previous metronidazole exposure on metronidazole-based second-line quadruple therapy for Helicobacter pylori infection;The Korean Journal of Internal Medicine;2020-09-01